David Wansboro
The deal is the firm’s 13th acquisition since its inception in 2019.
Aaron Lawson-Clark joins as an investment director and Emma Borrie Joins as an investment manager.
The investment will support CUBE's geographical expansion and will allow the company to build out its Automated Regulatory Intelligence platform.
The investment from Sagacity will support REaD’s growth.
Briar Chemicals is an agrochemical contract development and manufacturing organisation.
LuxVet is backed by Oaktree Capital and Cornerstone Investment Management.
Since signing the sale to Baker Hughes in August, BRUSH has closed on the acquisitions of Eta Projects, and KUS Power Engineering.
Former largest shareholder Finleap retains a minority stake.
Noden Pharma is a global specialty pharmaceutical company.
Buckthorn Partners has partnered with OEP in the deal for the firm, which also provides infra services.